Idorsia
Sandy Mahatme is currently a non-executive member of Idorsia. Prior to this, they served as the chief financial officer and chief business officer of Sarepta Therapeutics from 2012 to 2020. Before that, they were at Celgene Corporation from 2006 to 2012, where they were the senior vice president of corporate strategic development and initiatives. Sandy began their career at Pfizer Inc. in 1997 as senior counsel and held that position until 2006 when they joined Celgene.
Sandy Mahatme attended Cornell Law School and NYU Law School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.